My Medication Side Effects Are Too Popular

Although Li Xiner is not afraid, she firmly believes that Xinmei can rise as well. Those companies can't stop it, but it does limit the speed of Xinmei's development.

If there is an ally like Johnson & Johnson, Li Xiner is very welcome

The brand is well-known, but its share is not as good as that of Xinmei, and it will not take away the dominance, and it has great advantages in some fields

such a partner.very rare

Early the next morning, Edward came excitedly with the drafted contract.

"Mr. Fu, take a look at the contract drawn up according to your requirements. If you are not satisfied with the terms of the contract, we can negotiate.

Edward has been authorized by the board of directors to negotiate the licensing of this patent.

Fu Liang simply flipped through it and threw it to Xiao Wang next to him: "Take it and let the legal counsel pass over it, and give Edward another cup of coffee.

Edward felt a little strange. Usually, Fu Liang was not so willing to chat. Is this something else?

It won't be the condition that needs to be changed.

"Edward, in addition to the baby brands, there are also skin care products brands for girls, make-up brands, etc. under Johnson & Johnson, have you ever thought about becoming bigger and stronger?

Edward's heart moved, what is this thought, cooperation?

This is a good thing. Cooperating with Fu Liang will definitely not lose money, and the board of directors will definitely agree.

"Mr. Fu, of course we have thought about making it bigger and stronger, but in this business, we are not as good as those professional cosmetics companies, but if we can

With some new formulas, we are confident to expand the business scale and make more profits.

But we, Johnson & Johnson, have no plans to sell the brand. If President Fu wants to acquire our brand, I can’t agree, nor will the board of directors agree.

Fu Liang laughed: "How could I acquire an ally's brand, I'm talking about cooperation.

"Xinmei cooperates with your Johnson & Johnson's skin care products and color cosmetics business, we will expand this business together, and then jointly become the industry leader.

Edward Xin said that the last industry leader is not you.

But it would be nice to have them together.

Without Johnson & Johnson, with the strength and potential of Xinmei Cosmetics at this time, it will become the industry leader in three to five years, and will open up with other cosmetics companies

It is easy to catch up with the gap.

Cooperate with Johnson & Johnson, but shorten this time

No, Edward reacted, maybe he meant to avoid monopoly

Just like when Microsoft invested in Apple (Mr. Li’s), it was worried that Apple would go bankrupt, and Microsoft’s PC operating system would be a complete monopoly, and it would be heavily fined.

It was forced to split.

"Mr. Fu, of course we are willing to cooperate, but what do we have to pay and what can you give us?" Edward asked.

"I want all your makeup formulas, including free patent licenses. I can license you acne-fighting formulas, anti-wrinkle formulas and whitening formulas

But you have to pay.

Edward: "???

Our patent will be licensed to you for free, and your patent will be charged?

Is this fair cooperation?

How does he feel that this cooperation, like Johnson & Johnson is making a contribution?

Fu Liang looked at Edward with a smile, that's right, he just wanted to make wool again at Johnson & Johnson, and even let Johnson willingly take the wool himself.

Come down and deliver it to him!

PS: Ask for flowers, ask for evaluation, ask for automatic subscription!!!

Chapter Three Hundred and Twenty Eight: Makeup listed, shocking peers!

Edward reported the situation to the board of directors. After only ten minutes of discussion, the board of directors gave the answer - promise Fu Liang!

In their view, if they do not cooperate with Fu Liang, then Fu Liang is likely to choose other companies to cooperate.

The result is that Johnson & Johnson's market is compressed, or even eliminated by the market.

Although they paid a free patent license, they were also allowed to use Fu Liang's patented formula.

Fu Liang's formula is never authorized to outsiders.

They are the only ones that can work together

If you don't catch it, you're a fool!

The opportunity is presented to you,

Although it may not make a lot of money, it will definitely not be a loss. Fu Liang will not let their only ally, Johnson & Johnson, suffer a loss.

big negative impact.

Edward returned to Fu Liang's office: "Mr. Fu, the board of directors has agreed to your conditions, as long as the patent licensing fee is reasonable.

Fu Liang crossed Erlang's legs: "You already have a psychological reserve price, don't you, say it, I'll see if it's suitable.

Fu Gao played out of the way again, Edward was a little pity, he had never been so passive when negotiating

-Next, he directly stated the reserve price that the company gave him: "543% of the sales share can be paid according to the output.

hesitated

There are two modes of paying according to production and paying according to sales. According to production, you need to pay according to how much you produce, while paying according to sales is

It is how much you sell and how much you pay.

For example, if [-] million boxes are produced, [-] million boxes are sold, and the retail price of each box is ten dollars.

The billing model based on image production requires a patent licensing fee of US$[-] million, while the fee-based payment model only needs to pay [-] million US dollars.

Sheep Yuan.

This also involves the capital issue of a sales cycle. If you pay for production, you will pay for the production. You don’t have to wait for the sales to be paid back. The sooner you get it.

More money, obviously better

Because he is a friend, Fu Liang is not good at lowering the price over and over again, just look at the other party's reserve price.

Maybe Huaineng will continue to negotiate to lower the price, but it is so troublesome, anyway, he has made a lot of money.

"Yes, just follow this model. You can report to the headquarters and say that I want [-]% of the sales share, and you negotiated it." Fu Liang smiled.

said.

Edward is overjoyed. In this way, he has gained an extra credit out of thin air, and maybe his salary will increase by a bit.

"Thank you Mr. Fu, then I'll ask someone to draft a contract?

"No. Let Xiao Wang draw up the contract, you can take it back to see it, and if there is no problem, have your CEO sign and seal it and send it back.

The cooperation with Johnson & Johnson was very smooth, and the board of directors of Johnson & Johnson never imagined that Edward would directly disclose the reserve price to Fu Liang.

Of course, Edward still sat in Fu Liang's office for two hours before leaving, otherwise it would not show how hard he negotiated.

It was not until the evening that Edward reported the contract he had seen to the headquarters.

The president of Johnson & Johnson flew to Bingcheng with the official seal, merged the two cooperation agreements into one, signed and stamped, and officially took effect

Sui Xiner looked at the pile of makeup formulas in Fu Liang's hand and was overjoyed

She also thought about acquiring some makeup formulas before, but the top formulas,

, are in the hands of the top companies, and those companies will not sell.

Some companies also want to use this as a condition to exchange shares with Xinmei Cosmetics, and this is Li Xiner's turn not to agree.

Fortunately, there are now Johnson & Johnson makeup formulas.

Although Johnson & Johnson is not the top in the field of color cosmetics, it is also first-class. The product formula and quality are not bad, but the brand is worse.

The deepest impression of Johnson & Johnson is that of medical and nursing supplies companies, and the promotion of cosmetics is indeed a lot worse.

But low publicity and brand awareness does not mean that Johnson & Johnson's formula is not good enough.

In addition, Fu Liang can add some new ingredients to the product in the future to upgrade the product, so the current one is enough.

Aren't those cosmetic companies restricting the approval of new products?

Xinmei directly told the FDA in Europe and the United States this time that ours is the formula that Johnson & Johnson has been on the market for many years, should it be restricted?

(bbdc) Of course, the FDA has no reason to restrict any more, so Xinmei quickly launched a lot of make-up products, which really filled her counter with

A variety of products have been enriched and their product lines have been enriched.

In this way, the previously established sales channels are not wasted, and even some factories can be maintained as expected.

The significance of cooperating with Johnson & Johnson is also here. It can reduce the loss of expansion channels this year, and even ensure that there are no losses and profits.

Xinmei's makeup quickly appeared in the European and American markets, which surprised all the shareholders of L'Oreal.

"Can anyone tell me why Xinmei's make-up was approved by the FDA so quickly and went on the market? They didn't comply with the Cosmetics Industry Federation

new regulations? Didn't the FDA also pass this rule?

Paul looked at the other directors, which completely disrupted their plans.

They used their own new product launch delays to prevent Xinmei's new product launch, ensuring that they can still be the market leader in the next year or so.

But if Xinmei's products were not blocked from the market at this time, but their L'Oreal's new products were to be delayed, wouldn't that be digging their own graves?

Even spread out, they will become industry jokes.

A director said: "I know that I am in charge of the North American market, so I have heard a piece of news.

"Xinmei Cosmetics has signed an agreement with Johnson & Johnson to mutually license technology patents.